SUDEEP DHILLON, M.D.
Internal Medicine Physician in PENNINGTON, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
SUDEEP DHILLON, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 6,103 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 6K
- Part D claims, 2023
- 51%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
SUDEEP DHILLON, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
SUDEEP DHILLON, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about SUDEEP DHILLON, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in New Jersey
How Internal Medicine Physician compares to other specialties among New Jersey providers
Internal Medicine Physician share within New Jersey
Internal Medicine Physician is one of the more visible NUCC categories in New Jersey
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Medicare quality performance — MIPS
SUDEEP DHILLON, M.D.'s 2023 MIPS final score plotted against the Internal Medicine Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Internal Medicine Physician) — 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Internal Medicine Physician US NPIs
75/100 MIPS final score — 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Internal Medicine Physician.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
SUDEEP DHILLON, M.D. appears in the CMS NPPES registry as a Internal Medicine Physician provider holding M.D. credentials at 2 CAPITAL WAY STE 315, PENNINGTON, NJ, 08534, with a listed phone of (732) 668-2000. NPI 1780904094 was issued on 06/09/2010. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what DHILLON most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 6,103 prescription claims written by this provider, covering 635 Medicare beneficiaries and totaling roughly $3.5 million in drug spend, split 49% brand-name and 51% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Internal Medicine Physician is a high-volume specialty nationwide, with 172,858 enrolled providers across 56 states and an average of 2,716 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1780904094 |
|---|---|
| Specialty | Internal Medicine Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 06/09/2010 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm SUDEEP DHILLON, M.D.'s current license status, disciplinary history, and board certifications with the New Jersey State Board of Medical Examiners in New Jersey before relying on this page for a clinical or care decision.
How we sourced this profile
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for SUDEEP DHILLON, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.7K
Largest payer
Lilly USA, LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
49% brand-name claims vs 51% generic, on 6,103 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 14,579
- Total Day Supply
- 433,965
- Brand vs Generic
- 49% brand / 51% generic
- Brand Drug Cost
- $3.4M
- Generic Drug Cost
- $108K
- Antibiotic Claims
- 32
Patient Demographics
- Average Patient Age
- 73.5 years
- Avg HCC Risk Score
- 1.61
- Gender Split
- 59% female / 41% male
- Age Distribution
- <65: 58, 65-74: 292, 75-84: 220, 85+: 65
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What SUDEEP DHILLON, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
540 claims
- Ozempic
Ozempic
454 claims
- Metformin Hcl
Metformin Hcl
392 claims
- Tresiba Flextouch …
Tresiba Flextouch U-200
244 claims
- Rosuvastatin Calcium
Rosuvastatin Calcium
235 claims
- Atorvastatin Calcium
Atorvastatin Calcium
232 claims
- Repaglinide 180
Repaglinide
180 claims
- Xigduo Xr 163
Xigduo Xr
163 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 540 |
| Ozempic Semaglutide | 454 |
| Metformin Hcl | 392 |
| Tresiba Flextouch U-200 Insulin Degludec | 244 |
| Rosuvastatin Calcium | 235 |
| Atorvastatin Calcium | 232 |
| Repaglinide | 180 |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 163 |
| Metformin Hcl Er Metformin Hcl | 148 |
| Janumet Xr Sitagliptin Phos/Metformin Hcl | 147 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Internal Medicine Physician Overview
How SUDEEP DHILLON, M.D. fits within the Internal Medicine Physician landscape nationally.
SUDEEP DHILLON, M.D.'s 6,103 claims are above the specialty average of 2,716.
Nearby Internal Medicine Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as DHILLON.
Compare Internal Medicine Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore New Jersey
Frequently Asked Questions
What is SUDEEP DHILLON, M.D.'s specialty? ▼
How much does SUDEEP DHILLON, M.D. prescribe under Medicare Part D? ▼
What is SUDEEP DHILLON, M.D.'s Medicare quality score? ▼
Where is SUDEEP DHILLON, M.D. located? ▼
What is SUDEEP DHILLON, M.D.'s NPI number? ▼
Does SUDEEP DHILLON, M.D. prescribe more brand-name or generic drugs? ▼
How many Internal Medicine Physician providers are there in the US? ▼
What drugs does SUDEEP DHILLON, M.D. prescribe most often? ▼
Does SUDEEP DHILLON, M.D. accept Medicare? ▼
How can I verify SUDEEP DHILLON, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology